Latest Investments News

Beach Energy’s Q3 FY26 output rose 7% quarter-on-quarter, led by a 174% surge in Perth Basin production following Waitsia Gas Plant compressor commissioning. The company also secured new Queensland acreage and greenlit the Moomba Central Optimisation project, though weather disruptions trimmed Cooper Basin output and prompted a production guidance cut.

AusQuest has confirmed a vast copper-gold system at its Cangallo project in Peru, revealing broad mineralisation and multiple higher-grade zones. Meanwhile, exploration momentum continues in Australia under a South32 alliance, with key drilling programs poised to start.

Biome Australia’s Activated Probiotics brand surpasses one million boxes sold in Australia, approaches top pharmacy ranking, and launches nationally in Canada, setting the stage for FY26 profitability.

Central Petroleum lifted March quarter sales revenue to $11.3 million, driven by higher gas volumes and prices, while securing a significant multi-year gas supply deal with the Northern Territory Government that supports a 40% production capacity increase at Palm Valley.

Cambium Bio has clinched FDA agreement on a streamlined single pivotal Phase 3 trial for Elate Ocular®, cutting development complexity, while bolstering its cash position through a A$2.4 million strategic placement by major shareholder ZYBT.

Australian Mines Limited's latest scoping study for its Flemington Scandium Project reveals strong financial metrics and significant upside potential tied to scandium pricing, underscoring the project's strategic position in critical minerals.

Proteomics International is pivoting from research to disciplined commercial execution of its proteomics-based diagnostic tests, focusing on distributor partnerships and reimbursement pathways in Australia and the US.

St George Mining has expanded its Araxá rare earths-niobium resource by 75% to 70.91Mt at 4.06% TREO, positioning the project among the world’s largest carbonatite deposits. The company also acquired land for processing facilities and forged new downstream partnerships, supported by Minas Gerais state tax incentives.

LTR Pharma has wrapped up recruitment for its SPONTAN Phase II pharmacokinetic study, with interim results expected soon to bolster FDA approval efforts. Meanwhile, US commercial talks for ROXUS advance cautiously under the FDA 503(a) personalised medicine pathway.

European Resources has more than doubled its Korsnäs rare earth resource following a successful drilling program and metallurgical advances, underpinning a $3.4 million capital raise to fund further development.

Streamplay Studio delivers a fourth consecutive quarter of positive cash flow, underpinned by steady publishing revenues and strategic platform growth in new regions.

Whitehaven Coal’s March quarter production fell 14% due to seasonal wet weather in Queensland, but coal prices rose sharply and refinancing cut interest costs by up to A$55 million annually.